000 01377 a2200361 4500
005 20250516081514.0
264 0 _c20130211
008 201302s 0 0 eng d
022 _a1521-0669
024 7 _a10.3109/08880018.2011.627978
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorghorst, Stephan
245 0 0 _aPopulation pharmacokinetics of native Escherichia coli asparaginase.
_h[electronic resource]
260 _bPediatric hematology and oncology
_cMar 2012
300 _a154-65 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
650 0 4 _aAntineoplastic Agents
_xmetabolism
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aAsparaginase
_xmetabolism
650 0 4 _aChild
650 0 4 _aDouble-Blind Method
650 0 4 _aEscherichia coli
_xenzymology
650 0 4 _aHumans
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xblood
650 0 4 _aRecombinant Proteins
_xmetabolism
650 0 4 _aReproducibility of Results
700 1 _aPieters, Rob
700 1 _aKuehnel, Hans-Juergen
700 1 _aBoos, Joachim
700 1 _aHempel, Georg
773 0 _tPediatric hematology and oncology
_gvol. 29
_gno. 2
_gp. 154-65
856 4 0 _uhttps://doi.org/10.3109/08880018.2011.627978
_zAvailable from publisher's website
999 _c21584403
_d21584403